Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors.

2.50
Hdl Handle:
http://hdl.handle.net/10541/93435
Title:
Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors.
Authors:
Hildinger, M; Fehse, B; Hegewisch-Becker, S; John, J; Rafferty, Joseph A; Ostertag, W; Baum, C
Abstract:
When transferring the human multidrug resistance 1 (MDR1) cDNA, FMEV retroviral vectors mediate high-dose multidrug resistance and, thus, background-free selection in primary human hematopoietic progenitor cells. Here, we analyzed strategies for co-expression of a second gene from an FMEV:MDR1 vector. When linking the cDNAs with the internal ribosomal entry site (IRES) of poliovirus or retroviral splice signals, almost all multidrug-resistant hematopoietic colonies simultaneously coexpressed the 3' positioned second gene, neomycin-phosphotransferase (neoR). The IRES strategy allowed functional co-transfer of a 4.2-kb lacZ-neoR fusion gene, resulting in a total proviral genome size of 11 kb, corresponding to the packaging limit of retroviral vectors. Preselection based on multidrug resistance elevated the expression of the second gene in IRES constructs, but not in splice vectors. Moreover, three intriguing observations were made. First, up to 30% of cells preselected for functional transfer of the 3' positioned cDNA (neoR) showed infunctional MDR1; this occurred irrespective of the linking principle and was associated with instability of the MDR1 transcription unit. Second, the levels of multidrug resistance achieved with the co-expression vectors were moderately lower (15-30% reduced) than those mediated by the monocistronic counterpart. Third, transduction with FMEV:MDR1 co-expression vectors still resulted in high-dose cancer drug resistance and background-free selection of hematopoietic progenitor cells (including primary human CD34+ colony-forming units). Thus, for the first time, we describe MDR1 co-expression vectors that maintain their desired function in early and primary human hematopoietic cells. However, careful interpretation of the data reveals that further vector improvements are required to obtain clinically useful MDR1 co-expression vectors.
Affiliation:
Department of Cell and Virus Genetics, Heinrich-Pette-Institute for Experimental Virology and Immunology at the University of Hamburg, University Hospital Hamburg-Eppendorf, Germany.
Citation:
Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. 1998, 9 (1):33-42 Hum. Gene Ther.
Journal:
Human Gene Therapy
Issue Date:
1-Jan-1998
URI:
http://hdl.handle.net/10541/93435
DOI:
10.1089/hum.1998.9.1-33
PubMed ID:
9458240
Type:
Article
Language:
en
ISSN:
1043-0342
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorHildinger, Men
dc.contributor.authorFehse, Ben
dc.contributor.authorHegewisch-Becker, Sen
dc.contributor.authorJohn, Jen
dc.contributor.authorRafferty, Joseph Aen
dc.contributor.authorOstertag, Wen
dc.contributor.authorBaum, Cen
dc.date.accessioned2010-03-02T17:22:28Z-
dc.date.available2010-03-02T17:22:28Z-
dc.date.issued1998-01-01-
dc.identifier.citationDominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. 1998, 9 (1):33-42 Hum. Gene Ther.en
dc.identifier.issn1043-0342-
dc.identifier.pmid9458240-
dc.identifier.doi10.1089/hum.1998.9.1-33-
dc.identifier.urihttp://hdl.handle.net/10541/93435-
dc.description.abstractWhen transferring the human multidrug resistance 1 (MDR1) cDNA, FMEV retroviral vectors mediate high-dose multidrug resistance and, thus, background-free selection in primary human hematopoietic progenitor cells. Here, we analyzed strategies for co-expression of a second gene from an FMEV:MDR1 vector. When linking the cDNAs with the internal ribosomal entry site (IRES) of poliovirus or retroviral splice signals, almost all multidrug-resistant hematopoietic colonies simultaneously coexpressed the 3' positioned second gene, neomycin-phosphotransferase (neoR). The IRES strategy allowed functional co-transfer of a 4.2-kb lacZ-neoR fusion gene, resulting in a total proviral genome size of 11 kb, corresponding to the packaging limit of retroviral vectors. Preselection based on multidrug resistance elevated the expression of the second gene in IRES constructs, but not in splice vectors. Moreover, three intriguing observations were made. First, up to 30% of cells preselected for functional transfer of the 3' positioned cDNA (neoR) showed infunctional MDR1; this occurred irrespective of the linking principle and was associated with instability of the MDR1 transcription unit. Second, the levels of multidrug resistance achieved with the co-expression vectors were moderately lower (15-30% reduced) than those mediated by the monocistronic counterpart. Third, transduction with FMEV:MDR1 co-expression vectors still resulted in high-dose cancer drug resistance and background-free selection of hematopoietic progenitor cells (including primary human CD34+ colony-forming units). Thus, for the first time, we describe MDR1 co-expression vectors that maintain their desired function in early and primary human hematopoietic cells. However, careful interpretation of the data reveals that further vector improvements are required to obtain clinically useful MDR1 co-expression vectors.en
dc.language.isoenen
dc.subjectHaematopoietic Stem Cellsen
dc.subject.meshAntigens, CD34-
dc.subject.meshCell Culture Techniques-
dc.subject.meshCell Separation-
dc.subject.meshGene Expression-
dc.subject.meshGene Transfer Techniques-
dc.subject.meshGenes, MDR-
dc.subject.meshGenetic Vectors-
dc.subject.meshHematopoietic Stem Cells-
dc.subject.meshHumans-
dc.subject.meshRetroviridae-
dc.subject.meshSelection, Genetic-
dc.subject.meshTranscription, Genetic-
dc.titleDominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors.en
dc.typeArticleen
dc.contributor.departmentDepartment of Cell and Virus Genetics, Heinrich-Pette-Institute for Experimental Virology and Immunology at the University of Hamburg, University Hospital Hamburg-Eppendorf, Germany.en
dc.identifier.journalHuman Gene Therapyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.